The World Health Organization (WHO) estimates that if current trends persist, antibiotic resistance could cause 10 million deaths annually by 2050. The pharmaceutical industry...
At DrugBank, we’re dedicated to empowering pharmaceutical researchers with data that drives impactful results. Now, through our partnership with Snowflake, we’re making it even...
Data science has emerged as an innovative tool in the biopharmaceutical industry, leveraging the power of machine learning and artificial intelligence to drive innovation...
Deal StructuringDeal structuring in pharmaceutical M&A requires a balance of financial, legal, and strategic considerations. The optimal structure can significantly impact the financial and...
Biosimilars Biosimilars, while highly similar to their reference biopharmaceuticals, offer distinct advantages that position them as preferred therapeutic options in many cases. The primary advantage...
Oral drug delivery remains the gold standard in pharmaceutical administration. It offers convenience for patients, promotes medication adherence, and improves treatment outcomes. Compared to...
At DrugBank we’re committed to improving your daily research and drug development operations. Our latest enhancement, the DrugBank Data Dictionary, is designed to streamline...
The world of drug discovery is in a state of transformation, with advancements in biotechnology opening doors to new possibilities for targeting previously "undruggable"...
Drug development is challenging, including not only the complexities of biomolecular drug mechanisms but also the convolutions of regulatory pathways and commercialization strategies. To...
Investment Trends in Pharmaceutical Research and DevelopmentInvesting in the pharmaceutical sector presents a unique set of challenges and opportunities; let’s examine them in more...